Swiss National Bank
TERN

Swiss National Bank’s Terns Pharmaceuticals TERN Stock Holding History

Swiss National Bank’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Buy
+112,500
New +$4.62M ﹤0.01% 1263
2024
Q2 		– Sell
-61,000
Closed -$400K – 2515
2024
Q1 		$400K Sell
61,000
-6,900
-10% -$45.1K ﹤0.01% 2483
2023
Q4 		$441K Hold
67,900
– – ﹤0.01% 2496
2023
Q3 		$342K Hold
67,900
– – ﹤0.01% 2573
2023
Q2 		$594K Buy
+67,900
New +$791K ﹤0.01% 2506

Other funds holding TERN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Swiss National Bank's TERN Position: Q1 2026 in Review

Swiss National Bank opened a new position in Terns Pharmaceuticals (TERN) in Q1 2026: 112,500 shares worth $5.93M. The stake represents ﹤0.01% of the portfolio and ranks #1263 among its holdings. This is a return to the name: Swiss National Bank previously reported a position in TERN as recently as Q1 2024.

Swiss National Bank first reported a position in TERN in Q2 2023 and has held it in 5 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Swiss National Bank held 112,500 shares of Terns Pharmaceuticals worth $5.93M as of Q1 2026.
  • Terns Pharmaceuticals was a new Swiss National Bank position in Q1 2026.
  • Terns Pharmaceuticals made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1263 holding.
  • Swiss National Bank first reported a position in Terns Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.